Answers are grounded in this paper and cite their sources.
The oxaspiro‐phthalides ([n,5]‐oxaspirobenzalactones) bearing a phthalide spirofused to a cyclic‐ether of various sizes are frameworks found in bioactive natural products. The discovery and development of an alkynyl‐Prins cyclization based, strategy for the construction of structurally interesting, medicinally useful [5,5]‐[6,5]‐, and [7,5]‐oxaspirophthalides is reported in this manuscript. Our strategy represents a report on the construction of oxaspiro‐phthalides using the alkynyl‐Prins cyclization. This approach exhibits broad substrate scope with respect to carbonyl compounds and 2‐(alkynol)benzoates, with yields ranging between 43–98%. Isolation of intermediate, and further conversion of it to the end‐product supported the proposed mechanistic pathway.
No takes yet. Share an insight, caveat, or question.
Baire et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: